A few pills a day: that is what survival looks like for many ALK-positive lung cancer patients. But eventually, all patients develop resistance to this treatment.
No one yet knows what causes this form of lung cancer, and there is no cure.
More lives are lost to lung cancer than colorectal, breast and prostrate cancers combined. Only six percent of federal government dollars spent on cancer research are spent on lung cancer.
ALK Positive, a patient-led advocacy group, is leading the effort to fund groundbreaking research. In partnership with GO2, this research will pursue lower rates of resistance and increased rates of survival.
Your support is more than helpful, it has a genuine impact on the lives of our patients, because more research = more life.